nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart
|
Lehnart, Stephan E. |
|
2009 |
14 |
4 |
p. 213-224 |
artikel |
2 |
β-Adrenergic stimulation and myocardial function in the failing heart
|
El-Armouche, Ali |
|
2008 |
14 |
4 |
p. 225-241 |
artikel |
3 |
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
|
Teerlink, John R. |
|
2009 |
14 |
4 |
p. 243-253 |
artikel |
4 |
A novel approach to improve cardiac performance: cardiac myosin activators
|
Teerlink, John R. |
|
2009 |
14 |
4 |
p. 289-298 |
artikel |
5 |
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
|
Khan, Hashim |
|
2009 |
14 |
4 |
p. 277-287 |
artikel |
6 |
Levosimendan: from basic science to clinical practice
|
Parissis, John T. |
|
2008 |
14 |
4 |
p. 265-275 |
artikel |
7 |
Phosphodiesterase inhibition in heart failure
|
Movsesian, Matthew |
|
2008 |
14 |
4 |
p. 255-263 |
artikel |
8 |
Relaxin, a pleiotropic vasodilator for the treatment of heart failure
|
Teichman, Sam L. |
|
2008 |
14 |
4 |
p. 321-329 |
artikel |
9 |
Role of guanylate cyclase modulators in decompensated heart failure
|
Mitrovic, Veselin |
|
2009 |
14 |
4 |
p. 309-319 |
artikel |
10 |
Vasodilators in the treatment of acute heart failure: what we know, what we don’t
|
Metra, Marco |
|
2008 |
14 |
4 |
p. 299-307 |
artikel |